Alterations in muscarinic receptor neurotransmission in the central nervous system have been observed in Alzheimer's disease, narcolepsy, affective disorders, Parkinsonism and as a consequence of aging. As a result, significant effort has been expended in the design and development of muscarinic ligands that might be of potential therapeutic value. To date, five subtypes of muscarinic cholinergic receptors (mAChRs) have been described, three of which (m1, m3, m5) couple to a phosphoinositide-specific phospholipase C, with the attendant formation of inositol trisphosphate and diacylglycerol. Knowledge of the mechanisms underlying the regulation of mAChRs is important for evaluating the role played by mAChRs in signal transduction and in the rational design of therapeutic agents that could target this signaling pathway. In this proposal, we plan to extend our ongoing studies of the regulation of mAChR signaling to phosphoinositide turnover by examining the molecular mechanism underlying agonist-induced internalization of the receptor in human SH-SY5Y neuroblastoma cells. Specifically, the hypothesis to be tested is that the activity of phosphatidylinositol 4- kinase (PI4K), is an absolute requirement for the occurrence of receptor endocytosis. We will evaluate this hypothesis by the following approaches. By pharmacological means, we will determine the ability of known inhibitors of PI4K to inhibit mAChR endocytosis. By means of biochemical, immunological and cell biological approaches, we will determine the specific isoform(s) of PI4K that are involved in receptor endocytosis and their site of action within the endocytic cycle. To evaluate cause and effect, molecular genetic approaches will be employed to examine the effects of depletion and over-expression of PI4K on the extent of receptor internalization. Although phosphoinositides have been implicated in membrane trafficking events, most emphasis has been placed on the 3'-phosphoinositides. The present proposal focuses on the potential role played the quantitatively major 4'-phosphoinositides in this process, evidence for which is beginning to accumulate in both normal and pathological states. This proposal presents strong preliminary evidence linking PI4P synthesis to the internalization of mAChRs. It is likely that the knowledge gained from these studies will be of fundamental importance to understanding the regulation of cell signaling events in neural cells initiated not only by mAChRs, but also by other G-protein coupled receptors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS023831-13
Application #
6126115
Study Section
Special Emphasis Panel (ZRG1-MDCN-4 (01))
Program Officer
Michel, Mary E
Project Start
1986-09-01
Project End
2002-11-30
Budget Start
1999-12-01
Budget End
2000-11-30
Support Year
13
Fiscal Year
2000
Total Cost
$238,316
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Pharmacology
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Fisher, Stephen K; Heacock, Anne M; Keep, Richard F et al. (2010) Receptor regulation of osmolyte homeostasis in neural cells. J Physiol 588:3355-64
Foster, Daniel J; Vitvitsky, Victor M; Banerjee, Ruma et al. (2009) Muscarinic receptor regulation of osmosensitive taurine transport in human SH-SY5Y neuroblastoma cells. J Neurochem 108:437-49
Fisher, Stephen K; Cheema, Tooba A; Foster, Daniel J et al. (2008) Volume-dependent osmolyte efflux from neural tissues: regulation by G-protein-coupled receptors. J Neurochem 106:1998-2014
Foster, Daniel J; Heacock, Anne M; Keep, Richard F et al. (2008) Activation of muscarinic cholinergic receptors on human SH-SY5Y neuroblastoma cells enhances both the influx and efflux of K+ under conditions of hypo-osmolarity. J Pharmacol Exp Ther 325:457-65
Cheema, Tooba A; Fisher, Stephen K (2008) Cholesterol regulates volume-sensitive osmolyte efflux from human SH-SY5Y neuroblastoma cells following receptor activation. J Pharmacol Exp Ther 324:648-57
Cheema, Tooba A; Pettigrew, Veryan A; Fisher, Stephen K (2007) Receptor regulation of the volume-sensitive efflux of taurine and iodide from human SH-SY5Y neuroblastoma cells: differential requirements for Ca(2+) and protein kinase C. J Pharmacol Exp Ther 320:1068-77
Heacock, Anne M; Foster, Daniel J; Fisher, Stephen K (2006) Prostanoid receptors regulate the volume-sensitive efflux of osmolytes from murine fibroblasts via a cyclic AMP-dependent mechanism. J Pharmacol Exp Ther 319:963-71
Heacock, Anne M; Dodd, Michael S; Fisher, Stephen K (2006) Regulation of volume-sensitive osmolyte efflux from human SH-SY5Y neuroblastoma cells following activation of lysophospholipid receptors. J Pharmacol Exp Ther 317:685-93
Cheema, Tooba A; Ward, Caroline E; Fisher, Stephen K (2005) Subnanomolar concentrations of thrombin enhance the volume-sensitive efflux of taurine from human 1321N1 astrocytoma cells. J Pharmacol Exp Ther 315:755-63
Heacock, Anne M; Kerley, Daniel; Gurda, Grzegorz T et al. (2004) Potentiation of the osmosensitive release of taurine and D-aspartate from SH-SY5Y neuroblastoma cells after activation of M3 muscarinic cholinergic receptors. J Pharmacol Exp Ther 311:1097-104

Showing the most recent 10 out of 48 publications